Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Moss_2013_Br.J.Clin.Pharmacol_75_1231

Reference

Title: A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E
Ref: British Journal of Clinical Pharmacology, 75:1231, 2013 : PubMed

        



Related information

Inhibitor | MSF,


Citations formats

Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E (2013)
A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
British Journal of Clinical Pharmacology 75: 1231-9

Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E (2013)
British Journal of Clinical Pharmacology 75: 1231-9



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer